In the pathological progression of stroke, gelatinases including MMP-2 and MMP-9, possess the ability to activate numerous pro-inflammatory agents, including chemokine CXCL-8, interleukin 1β, and tumor necrosis factor α [38, 39]. This evidence concerns the gene CXCL8 and stroke disorder.